Literature DB >> 23282120

Serum uric acid, inflammation, and nondipping circadian pattern in essential hypertension.

Osman Turak1, Fırat Ozcan, Derya Tok, Ahmet Işleyen, Erdoğan Sökmen, Irfan Taşoğlu, Sinan Aydoğdu, Nihat Sen, Kim McFann, Richard J Johnson, Mehmet Kanbay.   

Abstract

Uric acid (UA) is independently associated with the emergence of hypertension. Nocturnal nondipping pattern of hypertension is associated with a greater risk of cardiovascular, renal, and cerebrovascular complications than dippers. The aim of the present study was to evaluate the relationship between the circadian blood pressure rhythm and UA level in patients with newly diagnosed essential hypertension. The study included 112 essential hypertensive patients and 50 healthy controls. The hypertensive patients were divided into two groups according to the results of 24-hour ambulatory blood pressure monitoring, including 60 dippers (35 men, 25 women; mean age, 52.6±15.8 years) and 52 nondippers (29 men, 23 women; mean age, 55.9±13.2 years). Nondippers had significantly higher serum UA levels than the dippers and controls (5.8±0.8, 5.1±0.9 and 4.2±0.9 mg/dL, respectively; P<.001). Serum high-sensitivity C-reactive protein levels were also significantly higher in the nondipper group than the other groups (P<.001) and significantly correlated with serum UA (r=0.358, P<.001). Multivariate logistic regression analysis revealed an independent positive association between serum UA levels and nondipper pattern (odds ratio, 2.28; 95% confidence interval, 1.33-3.94; P=.003). Serum UA is strongly and independently associated with the nondipper circadian pattern in essential hypertension.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23282120      PMCID: PMC8108262          DOI: 10.1111/jch.12026

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  49 in total

1.  Predictors of an increased risk of future hypertension in Utah. A screening analysis.

Authors:  S C Hunt; S H Stephenson; P N Hopkins; R R Williams
Journal:  Hypertension       Date:  1991-06       Impact factor: 10.190

2.  Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism.

Authors:  M Mazzali; J Hughes; Y G Kim; J A Jefferson; D H Kang; K L Gordon; H Y Lan; S Kivlighn; R J Johnson
Journal:  Hypertension       Date:  2001-11       Impact factor: 10.190

Review 3.  Hyperuricemia and incident hypertension: a systematic review and meta-analysis.

Authors:  Peter C Grayson; Seo Young Kim; Michael LaValley; Hyon K Choi
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-01       Impact factor: 4.794

4.  Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients.

Authors:  Alejandro de la Sierra; Josep Redon; José R Banegas; Julián Segura; Gianfranco Parati; Manuel Gorostidi; Juan J de la Cruz; Javier Sobrino; José L Llisterri; Javier Alonso; Ernest Vinyoles; Vicente Pallarés; Antonio Sarría; Pedro Aranda; Luis M Ruilope
Journal:  Hypertension       Date:  2009-01-26       Impact factor: 10.190

5.  Platelet activation and inflammatory response in patients with non-dipper hypertension.

Authors:  Mehmet Gungor Kaya; Mikail Yarlioglues; Ozgur Gunebakmaz; Ertugrul Gunturk; Tugrul Inanc; Ali Dogan; Nihat Kalay; Ramazan Topsakal
Journal:  Atherosclerosis       Date:  2009-09-12       Impact factor: 5.162

6.  Uric acid levels are associated with all-cause and cardiovascular disease mortality independent of systemic inflammation in men from the general population: the MONICA/KORA cohort study.

Authors:  Christa Meisinger; Wolfgang Koenig; Jens Baumert; Angela Döring
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-03-20       Impact factor: 8.311

7.  Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension.

Authors:  P Verdecchia; C Porcellati; G Schillaci; C Borgioni; A Ciucci; M Battistelli; M Guerrieri; C Gatteschi; I Zampi; A Santucci; C Santucci; G Reboldi
Journal:  Hypertension       Date:  1994-12       Impact factor: 10.190

8.  Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia.

Authors:  Laura G Sánchez-Lozada; Virgilia Soto; Edilia Tapia; Carmen Avila-Casado; Yuri Y Sautin; Takahiko Nakagawa; Martha Franco; Bernardo Rodríguez-Iturbe; Richard J Johnson
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-13

9.  Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators.

Authors:  M I Schmidt; R L Watson; B B Duncan; P Metcalf; F L Brancati; A R Sharrett; C E Davis; G Heiss
Journal:  Metabolism       Date:  1996-06       Impact factor: 8.694

10.  Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers.

Authors:  N Nakanishi; M Okamoto; H Yoshida; Y Matsuo; K Suzuki; K Tatara
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

View more
  33 in total

1.  Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.

Authors:  Petter Bjornstad; Lori Laffel; Jane Lynch; Laure El Ghormli; Ruth S Weinstock; Sherida E Tollefsen; Kristen J Nadeau
Journal:  Diabetes Care       Date:  2019-04-09       Impact factor: 19.112

2.  Serum uric acid is associated with arterial stiffness in men with newly diagnosed type 2 diabetes mellitus.

Authors:  J Zhang; G Xiang; L Xiang; H Sun
Journal:  J Endocrinol Invest       Date:  2014-01-09       Impact factor: 4.256

Review 3.  Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome.

Authors:  Kunal Chaudhary; Kunal Malhotra; James Sowers; Annayya Aroor
Journal:  Cardiorenal Med       Date:  2013-10       Impact factor: 2.041

Review 4.  Hyperuricemia and Hypertension: Links and Risks.

Authors:  Douglas J Stewart; Valerie Langlois; Damien Noone
Journal:  Integr Blood Press Control       Date:  2019-12-24

5.  Effect of plasma NOx values on cardiac function in obese hypertensive and normotensive pediatric patients.

Authors:  Meltem Akcaboy; Serdar Kula; Tayfun Göktas; Bijen Nazlıel; Semiha Terlemez; Nurullah Celik; Bülent Celik; Necla Buyan
Journal:  Pediatr Nephrol       Date:  2015-10-19       Impact factor: 3.714

Review 6.  The pathophysiology of hypertension in patients with obesity.

Authors:  Vincent G DeMarco; Annayya R Aroor; James R Sowers
Journal:  Nat Rev Endocrinol       Date:  2014-04-15       Impact factor: 43.330

Review 7.  The role of uric acid in mineral bone disorders in chronic kidney disease.

Authors:  Baris Afsar; Alan A Sag; Cinar Oztosun; Masanari Kuwabara; Mario Cozzolino; Adrian Covic; Mehmet Kanbay
Journal:  J Nephrol       Date:  2019-04-27       Impact factor: 3.902

8.  Higher Frequency of Nocturnal Blood Pressure Dipping but Not Heart Rate Dipping in Inflammatory Bowel Disease.

Authors:  Leili Pourafkari; Kourosh Masnadi-Shirazi; Mohammadreza Taban; Solmaz Mohammadi; Razieh Parizad; Samad Ghaffari; Arezou Tajlil; Mir Milad Pourmousavi Khoshknab; Nader D Nader
Journal:  Dig Dis Sci       Date:  2017-08-23       Impact factor: 3.199

Review 9.  Cardioprotective effects of SGLT2 inhibitors are possibly associated with normalization of the circadian rhythm of blood pressure.

Authors:  Asadur Rahman; Hirofumi Hitomi; Akira Nishiyama
Journal:  Hypertens Res       Date:  2017-01-19       Impact factor: 3.872

Review 10.  Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal?

Authors:  Zohreh Soltani; Kashaf Rasheed; Daniel R Kapusta; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.